In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Lundbeck buys spec pharma Ovation for $600mm plus earn-outs

Executive Summary

Only a few days after divesting nonstrategic investments--including its ownership in LifeCycle Pharma to the Lundbeck Foundation--H. Lundbeck AS has acquired private spec pharma Ovation Pharmaceuticals for $600mm in cash, significantly improving the European company's position in the US CNS market.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Full Acquisition
    • Payment Includes Cash
    • Acquisition of Private Biotech

Related Companies

UsernamePublicRestriction

Register